|
🐬
|
Composition and morphology of phosphate stones and their relation with etiology
M. Daudon,
H. Bouzidi,
Dominique Bazin
|
6 |
2010 |
6
🐬
|
|
🐬
|
Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients
M. Kerkeni,
A. Saïdi,
H. Bouzidi,
A. Letaief,
S. Ben Yahia,
M. Hammami
|
6 |
2013 |
6
🐬
|
|
🐬
|
Elevated serum levels of AGEs, sRAGE, and pentosidine in Tunisian patients with severity of diabetic retinopathy.
M. Kerkeni,
A. Saïdi,
H. Bouzidi,
S. Ben Yahya,
M. Hammami
|
5 |
2012 |
5
🐬
|
|
🦁
|
Between the ESP Classroom and the Workplace: Bridging the Gap.
H. Bouzidi
|
4 |
2009 |
4
🦁
|
|
🦁
|
Does urinary stone composition and morphology help for prediction of primary hyperparathyroidism?
H. Bouzidi,
David-Paul De Brauwere,
M. Daudon
|
4 |
2011 |
4
🦁
|
|
🐬
|
Methylglyoxal: A Relevant Marker of Disease Activity in Patients with Rheumatoid Arthritis
I. Knani,
H. Bouzidi,
S. Zrour,
N. Bergaoui,
M. Hammami,
M. Kerkeni
|
4 |
2018 |
4
🐬
|
|
🦁
|
[Characteristics of encrustation of ureteric stents in patients with urinary stones].
7 auth.
H. Bouzidi,
O. Traxer,
B. Doré,
J. Amiel,
H. Hadjadj,
P. Conort,
...
M. Daudon
|
4 |
2008 |
4
🦁
|
|
🦁
|
Lithiase de 2,8-dihydroxyadénine : du diagnostic à la prise en charge thérapeutique
H. Bouzidi,
B. Lacour,
M. Daudon
|
4 |
2007 |
4
🦁
|
